Companies / CONMED Corp

CONMED Corp

NYSE: CNMDCIK 816956LARGO, FL

Financials · FY2025

Revenue$1.37B
Net income$47.05M
Total debt$794.17M
Cash$25.86M
Diluted EPS$1.51
Shares outstanding30.0M

Ownership

30.0M shares outstanding · as of Jul 27, 2026
0.06%Insiders
Ownership
Insiders0.06%19,101
Institutions117.28%35,127,621
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 10

View all →
Insider% of sharesShares
Bronson David M.Director
0.06%17,909
Lalomia BrentExecutive VP RA, QA
<0.01%1,040
Kaye MarkDirector
<0.01%152
Beyer PatCEOPresident & CEO
——
Ferrell John D.Executive Vice President - HR
——
Foust Hollie KGeneral Counsel & Corp Sec
——
Moller Andrew JamesVP Corporate Controller
——
Pelletier Johonna MarieTreasurer and VP, Tax
——
Schabacker MatthewVP GM Advanced Surgical
——
Shagory Peter KEVP, STRAT & CORP DEVT
——

Institutional holders 270

View all →
HolderValue% of shares
BlackRock, Inc.$157.78M16.10%
Vanguard Group Inc$149.59M12.30%
Earnest Partners LLC$90.86M8.58%
Fuller &amp; Thaler Asset Management, Inc.$58.05M5.48%
Dimensional Fund Advisors LP$53.30M4.38%
State Street Corporation$46.39M4.73%
Bank of America Corp /De$43.30M3.56%
Sei Investments Co$39.83M3.28%
Capital Research Global Investors$37.57M3.09%
Cooke &amp; Bieler L.P.$35.23M2.90%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Dec 31, 2025Lalomia Brent
Executive
OtherCommon Stock$1.3K+32
+33.79%
125
<0.01% of shares
low
Mar 6, 2026Lalomia Brent
Executive
OtherCommon Stock$1.0K-26
-2.76%
915
<0.01% of shares
low
Jun 2, 2026Bronson David M.
Director
ExerciseCommon Stock$0+668
+3.87%
17,909
0.06% of shares
low
Mar 6, 2026Lalomia Brent
Executive
ExerciseCommon Stock$0+75
+8.66%
941
<0.01% of shares
low
Feb 24, 2026Kaye Mark
Director
ExerciseCommon Stock$0+152
152
<0.01% of shares
low
Jun 2, 2026Bronson David M.
Director
ExerciseRSUs (Restricted Stock Units)—-668
-100.00%
0
0.00% of shares
low
Jun 1, 2026Bronson David M.
Director
GrantRSUs (Restricted Stock Units)—+6K
5,772
0.02% of shares
low
Mar 2, 2026Schabacker Matthew
Executive
GrantOptions To Purchase Common Stock—+12K
11,646
0.04% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
CNMD——207410101—